Estrogen receptor-β is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast

[1]  T. Medley,et al.  Sex Steroids Modulate Human Aortic Smooth Muscle Cell Matrix Protein Deposition and Matrix Metalloproteinase Expression , 2005, Hypertension.

[2]  W. Kilarski,et al.  An ex vivo model for functional studies of myofibroblasts , 2005, Laboratory Investigation.

[3]  J. Gustafsson,et al.  Reflections on the discovery and significance of estrogen receptor beta. , 2005, Endocrine reviews.

[4]  P. Eriksson,et al.  Matrix metalloproteinase-26 (matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer. , 2004, Gynecologic oncology.

[5]  R. Coombes,et al.  The expression of oestrogen receptor (ER)-beta and its variants, but not ERalpha, in adult human mammary fibroblasts. , 2004, Journal of molecular endocrinology.

[6]  Georg Heinze,et al.  Estrogen‐metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women , 2004, Cancer.

[7]  L. Björnström,et al.  Estrogen receptor-dependent activation of AP-1 via non-genomic signalling , 2004, Nuclear receptor.

[8]  J. Hartman,et al.  Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D , 2004 .

[9]  R. Jaster,et al.  Involvement of AP-1 proteins in pancreatic stellate cell activation in vitro , 2004, International Journal of Colorectal Disease.

[10]  Margaret Warner,et al.  Regulation of Postnatal Lung Development and Homeostasis by Estrogen Receptor β , 2003, Molecular and Cellular Biology.

[11]  P. Bédard,et al.  Opposing Roles of C/EBPβ and AP-1 in the Control of Fibroblast Proliferation and Growth Arrest-specific Gene Expression* , 2003, Journal of Biological Chemistry.

[12]  L. Gebrim,et al.  The Effect of Tamoxifen on PCNA Expression in Fibroadenomas , 2003, The breast journal.

[13]  G. Pasquinelli,et al.  Smooth muscle cell differentiation in mammary stromo‐epithelial lesions with evidence of a dual origin: stromal myofibroblasts and myoepithelial cells , 2003, Histopathology.

[14]  F. Tavassoli,et al.  Periductal Stromal Tumor: A Rare Lesion With Low-Grade Sarcomatous Behavior , 2003, The American journal of surgical pathology.

[15]  R. Scolyer,et al.  Hormonal receptors expression in epithelial cells of mammary phyllodes tumors correlates with pathologic grade of the tumor: a multicenter study of 143 cases. , 2002, American journal of clinical pathology.

[16]  P. V. van Diest,et al.  Analysis of the progression of fibroepithelial tumours of the breast by PCR‐based clonality assay , 2002, The Journal of pathology.

[17]  S. Chu,et al.  Estrogen receptor-alpha and -beta expression in microvascular endothelial cells and smooth muscle cells of myometrium and leiomyoma. , 2002, Molecular human reproduction.

[18]  V. Speirs,et al.  Evaluation of seven oestrogen receptor β antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue , 2002, The Journal of pathology.

[19]  G. Striker,et al.  Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. , 2001, Journal of the American Society of Nephrology : JASN.

[20]  H. Harn,et al.  CD34, CD117, and actin expression in phyllodes tumor of the breast. , 2000, The Journal of surgical research.

[21]  C. Wells,et al.  Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast. , 2000, Human pathology.

[22]  J. Sloane,et al.  Abnormal regulation of the oestrogen receptor in benign breast lesions , 2000, Journal of clinical pathology.

[23]  C. Ruiz,et al.  Human decidual stromal cells express alpha-smooth muscle actin and show ultrastructural similarities with myofibroblasts. , 1999, Human reproduction.

[24]  H. Yoshida,et al.  Immunohistochemical study of hormone receptor and hormone-regulated protein expression in phyllodes tumour: comparison with fibroadenoma , 1998, Virchows Archiv.

[25]  C. Elston,et al.  Disease of the breast , 1998 .

[26]  T. Hirota,et al.  Histopathological study of stromal smooth muscle cells in fibroadenoma of the breast , 1996, Pathology international.

[27]  P. Möller,et al.  Antigenic profile of mammary fibroadenoma and cystosarcoma phyllodes. A study using antibodies to estrogen- and progesterone receptors and to a panel of cell surface molecules. , 1990, Pathology, research and practice.

[28]  W. Hanna,et al.  Cystosarcoma phylloides of the breast and its mimics. An immunohistochemical and ultrastructural study. , 1989, Archives of pathology & laboratory medicine.

[29]  G. Shyamala,et al.  Relationships between mammary estrogen receptor and estrogenic sensitivity. II. Binding of cytoplasmic receptor to chromatin. , 1986, Endocrinology.

[30]  R. Hoover,et al.  Estrogen replacement therapy and benign breast disease. , 1984, Journal of the National Cancer Institute.

[31]  P. Martin,et al.  Studies on clinical, hormonal and pathological correlations in breast fibroadenomas. , 1978, Journal of steroid biochemistry.

[32]  C. Foster.  Evaluation of seven oestrogen receptor beta antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue , 2003 .

[33]  S. Chu,et al.  Estrogen receptor-α and -β expression in microvascular endothelial cells and smooth muscle cells of myometrium and leiomyoma , 2002 .

[34]  Magali Ancelin,et al.  Presence of Estrogen Receptor b in the Human Endometrium through the Cycle: Expression in Glandular, Stromal, and Vascular Cells* , 2001 .

[35]  J. Gustafsson,et al.  Estrogen receptors a and b in the rodent mammary gland , 2000 .

[36]  J. Dixon,et al.  Cystic disease and fibroadenoma of the breast: natural history and relation to breast cancer risk. , 1991, British medical bulletin.